<DOC>
	<DOCNO>NCT02233218</DOCNO>
	<brief_summary>To investigate pharmacokinetic Drug-drug interaction</brief_summary>
	<brief_title>The Pharmacokinetic Drug-drug Interaction Safety Telmisartan/Amlodipine Rosuvastatin Healthy Male Volunteers</brief_title>
	<detailed_description>The purpose study investigate pharmacokinetic Drug-Drug ( telmisartan , amlodipine and/ rosuvastatin ) interaction safety healthy male volunteer .</detailed_description>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Healthy male volunteer age 19 50 2 . Participant body weight &gt; =55kg ( male ) body mass index ( BMI ) level 18~30 3 . Provision sign write informed consent 1 . History clinically significant disease 2 . History clinically significant hypersensitivity hypersensitivity reaction drug medication ( aspirin , antibiotic , etc . ) , include component Telmisartan , Rosuvastatin Amlodipine 3 . A history drug abuse presence positive reaction drug abuse potential urine screening drug 4 . Administration investigational product within 2 month prior first dose . 5 . Administration herbal medicine within 2 week administration ethical drug within 2 week administration overthecounter ( OTC ) drug within 1 week prior first dose investigational product ( investigator ( study doctor ) determine person meet criteria appropriately , relevant person may participate study ) 6 . Volunteers consider eligible clinical trial investigator ( study doctor ) due reason include laboratory test result , ECGs , vital sign .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>